Technology developer and producer Demcon further expands its technological capabilities with the introduction of Leap Development into the Demcon group. The company will continue its activities under the banner of Demcon electronics. The Deventer-based organization specializes in RF technology, wireless communication, embedded systems and integrated electronics development. With this latest addition, the Demcon group now has a specialized company that is dedicated entirely to electronics development projects and has state-of-the-art testing facilities.

Curix, part of the Demcon group, is developing groundbreaking technology for the treatment of life-threatening and debilitating neurological diseases. This new technology makes it possible to temporarily open the blood-brain barrier, addressing one of the biggest challenges in neurology. With this technology, drugs for brain tumors and neurodegenerative conditions, such as Alzheimer's and Parkinson's disease, can be delivered more efficiently. The participation of Twinning Participaties allows Curix to develop an injector system suitable for initial clinical studies in humans. “Our ultimate goal is to contribute to the development of improved treatments for neurological diseases”, says Peter Frinking, managing director and chief scientific officer at Curix.

Rijkswaterstaat has officially received its first DUS V1875 unmanned survey vessel (USV), named REMO 1, from Demcon unmanned systems, marking an important milestone in future-proofing their services. The handover took place during an official handover event organized by Rijkswaterstaat, where invited guests were shown a live demonstration of its advanced autonomous capabilities.

Dutch technology developer and manufacturer Demcon has sold its stake in Dutch United Instruments (DUI) to QED Technologies International. American company QED has now become the sole owner of DUI, which develops instruments for ultra-precise, contactless metrology of optical components. This makes DUI a perfect fit for the portfolio of QED, a leading provider of advanced production and metrology solutions for precision optics. “As a technology partner and co-investor, we have contributed to the development of DUI into a successful scale-up,” says Demcon CEO Dennis Schipper.